ICU MEDICAL INC/DE·4

Mar 16, 4:34 PM ET

Voigtlander Christian B. 4

4 · ICU MEDICAL INC/DE · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

ICU Medical COO Christian Voigtlander Receives 14,648 Shares (Withheld 8,096)

What Happened
Christian B. Voigtlander, Chief Operating Officer of ICU Medical (ICUI), had performance- and time‑based restricted stock units convert to common shares on 2026-03-15. A total of 14,648 shares were issued to him (11,400 and 3,248 awards). To cover tax withholding, 8,096 of those shares were surrendered at $125.85 per share, totaling $1,018,882. Net new shares to Voigtlander after withholding were 6,552. The awards included PRSUs that vested at 117% of target.

Key Details

  • Transaction date: 2026-03-15; Form 4 filed 2026-03-16 (timely).
  • Awards converted: 14,648 shares (reported as derivative exercises/conversions).
  • Shares withheld for taxes: 6,301 shares ($792,981) + 1,795 shares ($225,901) = 8,096 shares; withholding price used = $125.85/share; total ~$1,018,882.
  • Net shares received by insider: 6,552 shares.
  • Footnotes: PRSUs were performance-based (grant 3/15/2023) and certified at 117% of target by the Compensation Committee on 2/11/2026; RSUs/PRSUs have no exercise price.
  • Filing does not list total shares owned after the transaction in the provided excerpt.

Context

  • This was not an open‑market buy or sell but the settlement of restricted stock units (PRSU/RSU); such share issuances are routine compensation events rather than directional bets.
  • The tax liability was satisfied via share withholding (a common cashless settlement method).
  • No 10b5-1 plan, gift, or option purchase was reported; the conversion is reported under code M (exercise/conversion) and code F (payment of tax liability).

Insider Transaction Report

Form 4
Period: 2026-03-15
Voigtlander Christian B.
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2026-03-15+11,40051,154 total
  • Tax Payment

    Common Stock

    2026-03-15$125.85/sh6,301$792,98144,853 total
  • Exercise/Conversion

    Common Stock

    [F3]
    2026-03-15+3,24848,101 total
  • Tax Payment

    Common Stock

    2026-03-15$125.85/sh1,795$225,90146,306 total
  • Exercise/Conversion

    Common Stock

    [F3][F4]
    2026-03-153,2480 total
    Exercise: $0.00From: 2026-03-15Exp: 2026-03-15Common Stock (3,248 underlying)
  • Exercise/Conversion

    Performance Shares

    [F1][F5][F2]
    2026-03-1511,4000 total
    Exercise: $0.00From: 2026-03-15Exp: 2026-03-15Common Stock (11,400 underlying)
Footnotes (5)
  • [F1]These Securities are Performance-based Restricted Stock Units (PRSU).
  • [F2]Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
  • [F3]These securities are Restricted Stock Units.
  • [F4]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
  • [F5]There is neither a purchase price nor an exercise price for the PRSUs.
Signature
By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander|2026-03-16

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT